EMA — authorised 15 July 2022
- Application: EMEA/H/C/005641
- Marketing authorisation holder: Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
- Local brand name: Ganirelix Gedeon Richter
- Indication: Prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
- Status: approved